A cloud-compatible bioinformatics pipeline for ultrarapid pathogen identification from next-generation sequencing of clinical samples.
A cloud-compatible bioinformatics pipeline for ultrarapid pathogen identification from next-generation sequencing of clinical samples.
复制标题
DOI:
10.1101/gr.171934.113
复制
发表时间:
2014-07
期刊:
影响因子:
7
通讯作者:
Chiu CY
中科院分区:
文献类型:
--
作者:
Naccache SN;Federman S;Veeraraghavan N;Zaharia M;Lee D;Samayoa E;Bouquet J;Greninger AL;Luk KC;Enge B;Wadford DA;Messenger SL;Genrich GL;Pellegrino K;Grard G;Leroy E;Schneider BS;Fair JN;Martínez MA;Isa P;Crump JA;DeRisi JL;Sittler T;Hackett J Jr;Miller S;Chiu CY
Unbiased next-generation sequencing (NGS) approaches enable comprehensive pathogen detection in the clinical microbiology laboratory and have numerous applications for public health surveillance, outbreak investigation, and the diagnosis of infectious diseases. However, practical deployment of the technology is hindered by the bioinformatics challenge of analyzing results accurately and in a clinically relevant timeframe. Here we describe SURPI (“sequence-based ultrarapid pathogen identification”), a computational pipeline for pathogen identification from complex metagenomic NGS data generated from clinical samples, and demonstrate use of the pipeline in the analysis of 237 clinical samples comprising more than 1.1 billion sequences. Deployable on both cloud-based and standalone servers, SURPI leverages two state-of-the-art aligners for accelerated analyses, SNAP and RAPSearch, which are as accurate as existing bioinformatics tools but orders of magnitude faster in performance. In fast mode, SURPI detects viruses and bacteria by scanning data sets of 7–500 million reads in 11 min to 5 h, while in comprehensive mode, all known microorganisms are identified, followed by de novo assembly and protein homology searches for divergent viruses in 50 min to 16 h. SURPI has also directly contributed to real-time microbial diagnosis in acutely ill patients, underscoring its potential key role in the development of unbiased NGS-based clinical assays in infectious diseases that demand rapid turnaround times.
登录
查看更多内容
影响因子:
3.7
作者:
Dimon MT;Wood HM;Rabbitts PH;Arron ST
通讯作者:
Arron ST
影响因子:
48
作者:
Langmead, Ben;Salzberg, Steven L.
通讯作者:
Salzberg, Steven L.
影响因子:
3
作者:
Borozan I;Wilson S;Blanchette P;Laflamme P;Watt SN;Krzyzanowski PM;Sircoulomb F;Rottapel R;Branton PE;Ferretti V
通讯作者:
Ferretti V
影响因子:
6.7
作者:
Grard G;Fair JN;Lee D;Slikas E;Steffen I;Muyembe JJ;Sittler T;Veeraraghavan N;Ruby JG;Wang C;Makuwa M;Mulembakani P;Tesh RB;Mazet J;Rimoin AW;Taylor T;Schneider BS;Simmons G;Delwart E;Wolfe ND;Chiu CY;Leroy EM
通讯作者:
Leroy EM
影响因子:
9.6
作者:
Kollef, Katherhie E.;Schramm, Garrett E.;Kollef, Marin H.
通讯作者:
Kollef, Marin H.